CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma
Authors
Keywords
-
Journal
Pigment Cell & Melanoma Research
Volume 24, Issue 6, Pages 1148-1157
Publisher
Wiley
Online
2011-10-18
DOI
10.1111/j.1755-148x.2011.00929.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential PAX3 functions in normal skin melanocytes and melanoma cells
- (2011) Sandra Medic et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combination of targeted therapy and immunotherapy in melanoma
- (2011) Christian U. Blank et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The CSPG4-specific monoclonal antibody enhances and prolongs the effects of the BRAF inhibitor in melanoma cells
- (2011) Ling Yu et al. IMMUNOLOGIC RESEARCH
- Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
- (2011) Jian Wang et al. PLoS One
- Eradication of melanomas by targeted elimination of a minor subset of tumor cells
- (2011) P. Schmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transmembrane Signaling Proteoglycans
- (2010) John R. Couchman Annual Review of Cell and Developmental Biology
- NG2 cells: Properties, progeny and origin
- (2010) Jacqueline Trotter et al. BRAIN RESEARCH REVIEWS
- Activation of the Integrin Effector Kinase Focal Adhesion Kinase in Cancer Cells Is Regulated by Crosstalk between Protein Kinase C and the PDZ Adapter Protein mda-9/Syntenin
- (2010) C. Hwangbo et al. CANCER RESEARCH
- CSPG4 in Cancer: Multiple Roles
- (2010) X. Wang et al. CURRENT MOLECULAR MEDICINE
- Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse
- (2010) Feng-Ju Huang et al. DEVELOPMENTAL BIOLOGY
- CSPG4 Protein as a New Target for the Antibody-Based Immunotherapy of Triple-Negative Breast Cancer
- (2010) Xinhui Wang et al. JNCI-Journal of the National Cancer Institute
- Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-κB
- (2010) H Boukerche et al. ONCOGENE
- A role for the NG2 proteoglycan in glioma progression
- (2010) William B. Stallcup et al. Cell Adhesion & Migration
- Melanoma Proteoglycan Modifies Gene Expression to Stimulate Tumor Cell Motility, Growth, and Epithelial-to-Mesenchymal Transition
- (2009) J. Yang et al. CANCER RESEARCH
- Human bone marrow mesenchymal cells express NG2: possible increase in discriminative ability of flow cytometry during mesenchymal stromal cell identification
- (2009) Ilknur Kozanoglu et al. CYTOTHERAPY
- Heparan Sulfate Proteoglycan Modulation of Wnt5A Signal Transduction in Metastatic Melanoma Cells
- (2009) Michael P. O'Connell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancer Immunotherapy Targeting the High Molecular Weight Melanoma-Associated Antigen Protein Results in a Broad Antitumor Response and Reduction of Pericytes in the Tumor Vasculature
- (2008) P. C. Maciag et al. CANCER RESEARCH
- Hyaluronan and hyaluronidase in genitourinary tumors
- (2008) Melanie et al. Frontiers in Bioscience-Landmark
- Melanoma-associated chondroitin sulphate proteoglycan as a new target antigen for CD4+T cells in melanoma patients
- (2008) Cornelia Erfurt et al. INTERNATIONAL JOURNAL OF CANCER
- Interaction of Syntenin-1 and the NG2 Proteoglycan in Migratory Oligodendrocyte Precursor Cells
- (2008) Nivedita Chatterjee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
- (2008) M Chekenya et al. ONCOGENE
- mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src
- (2008) H. Boukerche et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells
- (2008) Bryan P. Toole et al. SEMINARS IN CANCER BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started